Aetna Inc



) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day down 0.2%. By the end of trading, Aetna Inc rose 86 cents (2.2%) to $39.93 on average volume. Throughout the day, 3.7 million shares of Aetna Inc exchanged hands as compared to its average daily volume of 4.6 million shares. The stock ranged in a price between $39.30-$40.04 after having opened the day at $39.32 as compared to the previous trading day's close of $39.07. Other companies within the Health Care sector that increased today were:

Marina Biotech Inc



), up 22.9%,

Inhibitex Inc



), up 20.2%,

YM Biosciences Inc



), up 19.8%, and

Dehaier Medical Systems



), up 14.3%.

Aetna Inc. operates as a diversified health care benefits company in the United States. Aetna Inc has a market cap of $13.73 billion and is part of the

health services

industry. The company has a P/E ratio of eight, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 17.7. Shares are up 28.1% year to date as of the close of trading on Monday.

TheStreet Ratings rates Aetna as a


. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, attractive valuation levels, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the negative front,

DARA Biosciences Inc



), down 23%,

Accelr8 Technology Corporation



), down 15.1%,

Marshall Edwards Inc



), down 13.9%, and

Response Genetics Inc



), down 13.8%, were all losers within the health care sector with

Celgene Corporation



) being today's health care sector loser.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR



) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care